Monthly revenue and year-on-year change for Lotus Pharm (1795) and LI Kang Biomedical (6242) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.
Year-on-year change
Monthly revenue history
| Month | Lotus Pharm | YoY | LI Kang Biomedical | YoY |
|---|---|---|---|---|
| Oct 2026 | NT$2.13 billion | -22.5% | NT$53 million | -8.1% |
| Sep 2026 | NT$2.77 billion | +128.0% | NT$41.9 million | +7.6% |
| Aug 2026 | NT$2.11 billion | +81.7% | NT$37 million | -0.5% |
| Jul 2026 | NT$2.49 billion | +3.9% | NT$42.1 million | -0.1% |
| Jun 2026 | NT$3.4 billion | +225.5% | NT$49.9 million | -8.3% |
| May 2026 | NT$2.32 billion | +105.8% | NT$58 million | +7.9% |
| Apr 2026 | NT$3.09 billion | +19.9% | NT$54.1 million | -4.2% |
| Mar 2026 | NT$4.35 billion | +173.6% | NT$53.5 million | -7.9% |
| Feb 2026 | NT$2.24 billion | +131.5% | NT$24.4 million | -44.6% |
| Jan 2026 | NT$2.05 billion | -5.5% | NT$43.7 million | +33.6% |
| Dec 2025 | NT$2.44 billion | +66.9% | NT$54.8 million | +3.3% |
| Nov 2025 | NT$1.06 billion | -0.2% | NT$59.2 million | +10.2% |
| Oct 2025 | NT$2.75 billion | +46.0% | NT$57.6 million | +0.8% |
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16